[
  {
    "ts": null,
    "headline": "A Look At Boston Scientific (BSX) Valuation As Analyst Optimism And Earnings Anticipation Build",
    "summary": "Boston Scientific (BSX) is drawing fresh attention as investors weigh upbeat analyst commentary, steady demand across key device franchises, and expectations ahead of its February 4 earnings release and projected profit of US$0.78 per share. See our latest analysis for Boston Scientific. At a share price of US$97.64, Boston Scientific has seen a 5.33% 30 day share price return and a 2.91% 1 year total shareholder return, with momentum recently supported by upbeat analyst commentary, product...",
    "url": "https://finnhub.io/api/news?id=5dbc1769712bb39f48e4fa5ecb5276e17da2d803daa3624c09b8372b1353462b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768018570,
      "headline": "A Look At Boston Scientific (BSX) Valuation As Analyst Optimism And Earnings Anticipation Build",
      "id": 138052513,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific (BSX) is drawing fresh attention as investors weigh upbeat analyst commentary, steady demand across key device franchises, and expectations ahead of its February 4 earnings release and projected profit of US$0.78 per share. See our latest analysis for Boston Scientific. At a share price of US$97.64, Boston Scientific has seen a 5.33% 30 day share price return and a 2.91% 1 year total shareholder return, with momentum recently supported by upbeat analyst commentary, product...",
      "url": "https://finnhub.io/api/news?id=5dbc1769712bb39f48e4fa5ecb5276e17da2d803daa3624c09b8372b1353462b"
    }
  }
]